Literature DB >> 25273222

Radiation-induced glioblastoma signaling cascade regulates viability, apoptosis and differentiation of neural stem cells (NSC).

Vladimir N Ivanov1, Tom K Hei.   

Abstract

Ionizing radiation alone or in combination with chemotherapy is the main treatment modality for brain tumors including glioblastoma. Adult neurons and astrocytes demonstrate substantial radioresistance; in contrast, human neural stem cells (NSC) are highly sensitive to radiation via induction of apoptosis. Irradiation of tumor cells has the potential risk of affecting the viability and function of NSC. In this study, we have evaluated the effects of irradiated glioblastoma cells on viability, proliferation and differentiation potential of non-irradiated (bystander) NSC through radiation-induced signaling cascades. Using media transfer experiments, we demonstrated significant effects of the U87MG glioblastoma secretome after gamma-irradiation on apoptosis in non-irradiated NSC. Addition of anti-TRAIL antibody to the transferred media partially suppressed apoptosis in NSC. Furthermore, we observed a dramatic increase in the production and secretion of IL8, TGFβ1 and IL6 by irradiated glioblastoma cells, which could promote glioblastoma cell survival and modify the effects of death factors in bystander NSC. While differentiation of NSC into neurons and astrocytes occurred efficiently with the corresponding differentiation media, pretreatment of NSC for 8 h with medium from irradiated glioblastoma cells selectively suppressed the differentiation of NSC into neurons, but not into astrocytes. Exogenous IL8 and TGFβ1 increased NSC/NPC survival, but also suppressed neuronal differentiation. On the other hand, IL6 was known to positively affect survival and differentiation of astrocyte progenitors. We established a U87MG neurosphere culture that was substantially enriched by SOX2(+) and CD133(+) glioma stem-like cells (GSC). Gamma-irradiation up-regulated apoptotic death in GSC via the FasL/Fas pathway. Media transfer experiments from irradiated GSC to non-targeted NSC again demonstrated induction of apoptosis and suppression of neuronal differentiation of NSC. In summary, intercellular communication between glioblastoma cells and bystander NSC/NPC could be involved in the amplification of cancer pathology in the brain.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25273222      PMCID: PMC4378234          DOI: 10.1007/s10495-014-1040-x

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  54 in total

1.  Human neural stem cell transplantation ameliorates radiation-induced cognitive dysfunction.

Authors:  Munjal M Acharya; Lori-Ann Christie; Mary L Lan; Erich Giedzinski; John R Fike; Susanna Rosi; Charles L Limoli
Journal:  Cancer Res       Date:  2011-07-14       Impact factor: 12.701

Review 2.  DNA damage-induced cell death: lessons from the central nervous system.

Authors:  Helena Lobo Borges; Rafael Linden; Jean Y J Wang
Journal:  Cell Res       Date:  2008-01       Impact factor: 25.617

3.  Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.

Authors:  Jo Meagan Garner; Meiyun Fan; Chuan He Yang; Ziyun Du; Michelle Sims; Andrew M Davidoff; Lawrence M Pfeffer
Journal:  J Biol Chem       Date:  2013-07-31       Impact factor: 5.157

4.  Positive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandins.

Authors:  B Poligone; A S Baldwin
Journal:  J Biol Chem       Date:  2001-08-16       Impact factor: 5.157

Review 5.  Radiation induced non-targeted response: mechanism and potential clinical implications.

Authors:  Tom K Hei; Hongning Zhou; Yunfei Chai; Brian Ponnaiya; Vladimir N Ivanov
Journal:  Curr Mol Pharmacol       Date:  2011-06       Impact factor: 3.339

6.  Irradiation induced clonogenic cell death of human malignant glioma cells does not require CD95/CD95L interactions.

Authors:  J R Streffer; M Schuster; U Pohl; C Belka; J Dichgans; M Bamberg; M Weller
Journal:  Anticancer Res       Date:  1999 Nov-Dec       Impact factor: 2.480

Review 7.  Molecular mechanisms of necroptosis: an ordered cellular explosion.

Authors:  Peter Vandenabeele; Lorenzo Galluzzi; Tom Vanden Berghe; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2010-09-08       Impact factor: 94.444

8.  Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells.

Authors:  Vladimir N Ivanov; Hongning Zhou; Michael A Partridge; Tom K Hei
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

9.  DNA damage in mammalian neural stem cells leads to astrocytic differentiation mediated by BMP2 signaling through JAK-STAT.

Authors:  Leonid Schneider; Serena Pellegatta; Rebecca Favaro; Federica Pisati; Paola Roncaglia; Giuseppe Testa; Silvia K Nicolis; Gaetano Finocchiaro; Fabrizio d'Adda di Fagagna
Journal:  Stem Cell Reports       Date:  2013-07-25       Impact factor: 7.765

10.  What is the Role of the Bystander Response in Radionuclide Therapies?

Authors:  Darren Brady; Joe M O'Sullivan; Kevin M Prise
Journal:  Front Oncol       Date:  2013-08-19       Impact factor: 6.244

View more
  13 in total

1.  A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.

Authors:  Ruichao Chai; Kenan Zhang; Kuanyu Wang; Guanzhang Li; Ruoyu Huang; Zheng Zhao; Yanwei Liu; Jing Chen
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-03       Impact factor: 4.553

2.  Downregulation of Survivin Gene Expression Affects Ionizing Radiation Resistance of Human T98 Glioma Cells.

Authors:  Jicheng Li; Yong Han; Dai Zhou; Youxin Zhou; Ming Ye; Hangzhou Wang; Ziwei Du
Journal:  Cell Mol Neurobiol       Date:  2017-11-02       Impact factor: 5.046

3.  Regulation of viability, differentiation and death of human melanoma cells carrying neural stem cell biomarkers: a possibility for neural trans-differentiation.

Authors:  Vladimir N Ivanov; Tom K Hei
Journal:  Apoptosis       Date:  2015-07       Impact factor: 4.677

4.  Risk of Second Primary Neoplasms of the Central Nervous System.

Authors:  Elisa K Liu; Cheongeun Oh; Douglas Kondziolka; Erik P Sulman
Journal:  Adv Radiat Oncol       Date:  2022-04-18

Review 5.  Effects of radiation on metastasis and tumor cell migration.

Authors:  Marta Vilalta; Marjan Rafat; Edward E Graves
Journal:  Cell Mol Life Sci       Date:  2016-03-29       Impact factor: 9.261

6.  Radiation-induced bystander effect in non-irradiated glioblastoma spheroid cells.

Authors:  Fahime Faqihi; Ali Neshastehriz; Shokouhozaman Soleymanifard; Robabeh Shabani; Nazila Eivazzadeh
Journal:  J Radiat Res       Date:  2015-07-09       Impact factor: 2.724

7.  Regulation of human glioblastoma cell death by combined treatment of cannabidiol, γ-radiation and small molecule inhibitors of cell signaling pathways.

Authors:  Vladimir N Ivanov; Jinhua Wu; Tom K Hei
Journal:  Oncotarget       Date:  2017-05-27

8.  Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study.

Authors:  Ewa Izycka-Swieszewska; Ewa Bien; Joanna Stefanowicz; Edyta Szurowska; Ewa Szutowicz-Zielinska; Magdalena Koczkowska; Dawid Sigorski; Wojciech Kloc; Wojciech Rogowski; Elzbieta Adamkiewicz-Drozynska
Journal:  Biomed Res Int       Date:  2018-04-01       Impact factor: 3.411

9.  A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells.

Authors:  Anaïs Balbous; Ulrich Cortes; Karline Guilloteau; Pierre Rivet; Baptiste Pinel; Mathilde Duchesne; Julie Godet; Odile Boissonnade; Michel Wager; René Jean Bensadoun; Jean-Claude Chomel; Lucie Karayan-Tapon
Journal:  BMC Cancer       Date:  2016-08-05       Impact factor: 4.430

10.  NFAT3/c4-mediated excitotoxicity in hippocampal apoptosis during radiation-induced brain injury.

Authors:  Meiling Xu; Qiuhong Fan; Junjun Zhang; Yanfang Chen; Ruizhe Xu; Liesong Chen; Peifeng Zhao; Ye Tian
Journal:  J Radiat Res       Date:  2017-11-01       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.